Crinetics Pharmaceuticals, Inc.
corporate_fare Company Profile
Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 29 items for CRNX at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Crinetics Submits Palsonify MAA in Brazil, Expanding Global Reach for Acromegaly Treatment
- Crinetics Pharmaceuticals CDOO Resigns to Pursue New Opportunity
- Crinetics Pharmaceuticals Reports First Product Revenue, Positive EU Regulatory Opinion for PALSONIFY, and Pipeline Advancements
- Crinetics Reports First PALSONIFY Product Revenue of $5.4M in Q4 2025, Strong Launch, Positive EU Opinion, and Pipeline Progress
- Crinetics Reports Early PALSONIFY Revenue, Strong Cash, and Advances Multiple Programs to Phase 3
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$7.7M
Net Income
-$465.32M
Diluted EPS
-$4.95
Op. Cash Flow
-$377.92M
Free Cash Flow
-$383.68M
Gross Profit
$6.62M
Operating Income
-$516.77M
Cash & Equivalents
$101.54M
Debt / Equity
0.00×
Net Margin
-60.46×
Shares Outstanding
95.58M sh
Source: 10-K · filed 2026-02-26 · accession 0001658247-26-000012